Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

0.54
Delayed Data
As of 3:58pm ET
 -0.01 / -1.82%
Today’s Change
0.22
Today|||52-Week Range
1.98
-22.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues4.1M47.8M5.6M5.0M
 
 
 
 
 
Cost of Goods Sold--7.9M12.5M7.3M
 
 
 
 
Depreciation And Amortization4.3M3.3M3.4M3.0M
 
 
 
 
 
 
Operating ExpensesGross Income--36.6M-10.4M-5.3M
 
 
 
 
General Expenses27.2M34.9M27.1M21.2M
 
 
 
 
 
Research And Development21.8M19.1M13.7M11.7M
 
 
 
 
 
Total Operating Expenses31.5M46.1M43.0M31.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.5M1.8M-37.5M-26.5M
 
 
 
 
 
Extraordinary Credit479.0K0.008.1M27.1M
 
 
 
 
Extraordinary Charge0.00-39.9M---13.6M
 
 
 
Interest Expense On Debt1.4M1.5M7.4M8.4M
 
 
 
 
 
Other Expenses0.000.000.0028.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-28.0M-39.6M-36.7M-21.3M
 
 
 
 
 
Net Income-28.0M-39.6M-36.7M-21.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.5M16.7M17.8M19.8M
 
 
 
 
 
Shares To Calculate EPS Diluted12.5M16.7M17.8M19.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.24-$2.38-$2.07-$1.08
 
 
 
 
 
EPS Diluted-$2.24-$2.38-$2.07-$1.08